ROSANNE CASAL: Open Payments
NPI 1659648111 · CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$306 in 8 payments from 5 companies in 2025. Trend: 2023 $262 · 2024 $311 · 2025 $306
Food & beverage: $306
| Company | Payments | Amount |
|---|---|---|
| Pharmacosmos Therapeutics Inc. | 1 | $150 |
| ABBVIE INC. | 2 | $51 |
| Novartis Pharmaceuticals Corporation | 2 | $46 |
| Merck Sharp & Dohme LLC | 2 | $37 |
| Incyte Corporation | 1 | $21 |
Products named: MONOFERRIC, IMBRUVICA, KEYTRUDA, SCEMBLIX, PLUVICTO, JAKAFI.
Industry payments across OH — which companies pay providers there.
